MAZE THERAPEUTICS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-03-25: Form 10-K; Item Smaller reporting company; As filed Yes.
- 2025-11-06: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2025-08-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2025-05-14: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2026-03-25 | 10-K | Smaller reporting company | Yes |
| 2025-11-06 | 10-Q | Smaller reporting company | Yes |
| 2025-08-12 | 10-Q | Smaller reporting company | Yes |
| 2025-05-14 | 10-Q | Smaller reporting company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |